SO
VERA icon

STRS Ohio’s Vera Therapeutics VERA Stock Holding History

STRS Ohio’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Buy
+6,200
New +$267K ﹤0.01% 1395
2025
Q1 		– Sell
-1,800
Closed -$76.1K – 2026
2024
Q4 		$76.1K Sell
1,800
-2,100
-54% -$93K ﹤0.01% 1674
2024
Q3 		$172K Buy
3,900
+3,500
+875% +$133K ﹤0.01% 1595
2024
Q2 		$14.5K Sell
400
-1,500
-79% -$59.5K ﹤0.01% 1906
2024
Q1 		$81K Buy
1,900
+600
+46% +$21.4K ﹤0.01% 1708
2023
Q4 		$19K Buy
+1,300
New +$16.5K ﹤0.01% 1850
2022
Q4 		– Sell
-1,600
Closed -$34K – 2076
2022
Q3 		$34K Hold
1,600
– – ﹤0.01% 1880
2022
Q2 		$21K Hold
1,600
– – ﹤0.01% 1962
2022
Q1 		$37K Hold
1,600
– – ﹤0.01% 1984
2021
Q4 		$42K Hold
1,600
– – ﹤0.01% 2030
2021
Q3 		$27K Buy
+1,600
New +$28.6K ﹤0.01% 2158

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STRS Ohio's VERA Position: Q1 2026 in Review

STRS Ohio opened a new position in Vera Therapeutics (VERA) in Q1 2026: 6,200 shares worth $249K. The stake represents ﹤0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: STRS Ohio previously reported a position in VERA as recently as Q4 2024.

STRS Ohio first reported a position in VERA in Q3 2021 and has held it in 11 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • STRS Ohio held 6,200 shares of Vera Therapeutics worth $249K as of Q1 2026.
  • Vera Therapeutics was a new STRS Ohio position in Q1 2026.
  • Vera Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1395 holding.
  • STRS Ohio first reported a position in Vera Therapeutics in Q3 2021 and has held it in 11 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.